Pressure Biosciences (PBIO) 0.5000 $PBIO
Pressure BioSciences, Inc. Selected to Present at Cavendish Global Health Impact Forum
PR Newswire - Mon May 05, 7:49AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
, a worldwide leader in the development and sale of high pressure-based sample preparation systems to the life sciences research market, today announced that it has been selected to present at the Cavendish Global Health Impact Forum taking place May 5-7 New York, NY. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission, the Forum showcases presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, health-policy experts, and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis, and treatment.
Pressure BioSciences, Inc. to Present at the Growth Capital Expo 2014 Investment Conference
PR Newswire - Mon Apr 28, 7:08AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the inaugural Growth Capital Expo Investment Conference being held from April 29 to May 1, 2014 at Caesars Palace in Las Vegas, Nevada.
Merriman Capital Markets Advisory Group Hosts Spotlight: Healthcare Investor Event
Thomson Reuters ONE - Wed Apr 16, 8:07AM CDT
SAN FRANCISCO - April 16, 2014 - Merriman Capital, Inc. ("Merriman" , a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), hosted a highly engaging investor event on April 10, 2014 that highlighted three of its healthcare-focused Capital Markets Advisory Clients.
Merriman Capital Markets Group Hosting Healthcare Spotlight Investor Event
Thomson Reuters ONE - Thu Apr 03, 3:05PM CDT
SAN FRANCISCO - April 3, 2014 - Merriman Capital, Inc. ("Merriman" , a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), is pleased to announce that it will be hosting an investor event highlighting three of its healthcare-focused Capital Markets Advisory Clients.
Pressure BioSciences, Inc. Reports Strong Fourth Quarter and Fiscal Year 2013 Financial Results
PR Newswire - Tue Apr 01, 9:42AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced financial results for the three-month period and fiscal year ended December 31, 2013 and provided a business update.
Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2013 Financial Results and Provide a Business Update
PR Newswire - Mon Mar 31, 8:37AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company" today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below:
Pressure BioSciences Inc. Exclusive Interview for the Interlinked Investment News Channel on InterlinkedTV
PRWeb - Fri Mar 21, 3:37PM CDT
Pressure BioSciences Inc. was one of the presenting companies interviewed at the recent FSXinterlinked Investment Conference, held at the Ritz Carlton in Dallas, Texas.
Pressure BioSciences Announces the Release and Initial Sale of the Barocycler HUB880, a "First-in-Kind" Ultra High Pressure Bench-top Instrument System
PR Newswire - Wed Mar 19, 9:23AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced the commercial release of the Barocycler HUB880, the newest addition to the Company's growing line of high-pressure instrument systems. The Company also announced the sale (and shipment) of its first HUB880 system to Dr. Wayne Hubbell of the University of California Los Angeles (UCLA). PBI plans to showcase the HUB880 at the upcoming U.S. Human Proteome Organization's 10th Annual Conference to be held at the Westin-Seattle (WA), April 6-9, 2014.
Pressure BioSciences, Inc. to Present at the NIBA Florida Investment Conference
PR Newswire - Thu Feb 27, 8:43AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the Florida Investment Conference of the National Investment Banking Association ("NIBA" . The NIBA Investment Conference is being held from February 26-28 at the Riverside Hotel in Ft. Lauderdale, Florida. Mr. Schumacher is scheduled to present today (February 27th) at 2:50 pm EST in the Himarshee Ballroom.
TriStar Wellness Solutions® Obtains New Patent for HemCon's Chitosan Technology in Japan
PR Newswire - Wed Feb 12, 7:30AM CST
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has recently been awarded a new patent that supports our emerging status in the Japanese medical/dental markets. Patent application number 2008-537698 has received final approval for issuance to HemCon Medical Technologies® Inc., a wholly owned subsidiary of TriStar Wellness Solutions, and is specific to HemCon's chitosan-based dental sponges for the Japanese market.
Pressure BioSciences Introducing New Technology for Its Pressure Cycling Platform
PRWeb - Thu Jan 16, 5:14AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) record sales in the third-quarter have given the company a bright future. Analysts are even more optimistic about 2014 because the company is going to introduce a breakthrough technology for use in its pressure cycling platform that uses an HT system.
Merriman Capital to Host Pressure BioSciences, Inc. Investor Call at 4:30 p.m. EST on Thursday, December 12, 2013
PR Newswire - Wed Dec 11, 8:02AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Merriman Capital, Inc. ("Merriman" , a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), will host an investor call for PBI on Thursday, December 12, 2013 at 4:30 p.m. EST. Pressure BioSciences CEO Richard T. Schumacher and Board Chairman Jeffrey N. Peterson will provide an update on the Company, including a review of the achievements of 2013 and stated goals for 2014, via a webcast with an accompanying PowerPoint presentation.
Merriman Capital to Host Pressure BioSciences, Inc. Investor Call
Thomson Reuters ONE - Mon Dec 09, 8:24AM CST
SAN FRANCISCO - December 9, 2013 - Merriman Capital, Inc. ("Merriman" , a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced today that it will host a conference call for Pressure BioSciences, Inc. ("Pressure BioSciences" (OTCQB: PBIO) on Thursday, December 12, 2013 at 4:30 p.m. EST. Pressure BioSciences CEO Richard T. Schumacher and Chairman Jeffrey N. Peterson will provide comments on the Company with an accompanying presentation.
Pressure BioSciences, Inc. -- (PBIO) Featured in Flaherty Financial News Newsletter #40
Marketwire - Mon Nov 25, 8:02AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) led off snapshots of four presentations featured in the November 22, 2013 issue of Flaherty Financial News Newsletter. PBIO's record third quarter and year-to-date 2013 sales, guidance for a strong fourth quarter and expectations to reach breakeven in two years were discussed. However, the highlight was "a core technology breakthrough." CEO Ric Schumacher believes their new high throughput Barocycler instruments will be ready for release by mid-June 2014, and that it is a "game changer." The breakthrough will automate its current highly manual test tube sample preparation system and will allow it to be directly integrated with thousands of downstream instruments now in use by scientists in an estimated 80,000 laboratories worldwide.
Pressure BioSciences, Inc. Discusses Record Third Quarter Revenue, Strong Fourth Quarter Guidance, Significant Progress on New Instrument Systems, and Expectation to Pay-Off All Outstanding Convertible Notes at the SeeThruEquity Financial Conference
PR Newswire - Mon Nov 18, 12:20PM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Mr. Richard T. Schumacher, the Company's President and CEO, presented a business and financial update on the Company at the November 12th SeeThruEquity Investor Conference in New York City.
Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
PR Newswire - Thu Nov 07, 12:33PM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced record financial results for the three and nine-month periods ended September 30, 2013 and provided a business update.
OTC Daily Alert Stock Watch - Pressure BioSciences, Inc. (OTCQB: PBIO)
WorldStockWire - Fri Sep 06, 10:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Kevin Pollack of Pressure BioSciences, Inc. (PBIO)-OTC Markets bought Shares of PBIO
M2 - Mon Aug 26, 9:03AM CDT
Reported by InsiderCow.com at 2013-08-23 14:51:06 ET
Pressure BioSciences, Inc. Reports Second Quarter 2013 Financial Results
PR Newswire - Thu Aug 15, 9:06AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced financial results for the three and six-month periods ended June 30, 2013 and provided a business update.
Pressure BioSciences, Inc. Selected to Present at Cavendish Global Health Impact Forum
PR Newswire - Mon May 05, 7:49AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
, a worldwide leader in the development and sale of high pressure-based sample preparation systems to the life sciences research market, today announced that it has been selected to present at the Cavendish Global Health Impact Forum taking place May 5-7 New York, NY. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission, the Forum showcases presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, health-policy experts, and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis, and treatment. Pressure BioSciences, Inc. to Present at the Growth Capital Expo 2014 Investment Conference
PR Newswire - Mon Apr 28, 7:08AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the inaugural Growth Capital Expo Investment Conference being held from April 29 to May 1, 2014 at Caesars Palace in Las Vegas, Nevada. Merriman Capital Markets Advisory Group Hosts Spotlight: Healthcare Investor Event
Thomson Reuters ONE - Wed Apr 16, 8:07AM CDT
SAN FRANCISCO - April 16, 2014 - Merriman Capital, Inc. ("Merriman"
, a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), hosted a highly engaging investor event on April 10, 2014 that highlighted three of its healthcare-focused Capital Markets Advisory Clients. Merriman Capital Markets Group Hosting Healthcare Spotlight Investor Event
Thomson Reuters ONE - Thu Apr 03, 3:05PM CDT
SAN FRANCISCO - April 3, 2014 - Merriman Capital, Inc. ("Merriman"
, a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), is pleased to announce that it will be hosting an investor event highlighting three of its healthcare-focused Capital Markets Advisory Clients. Pressure BioSciences, Inc. Reports Strong Fourth Quarter and Fiscal Year 2013 Financial Results
PR Newswire - Tue Apr 01, 9:42AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced financial results for the three-month period and fiscal year ended December 31, 2013 and provided a business update. Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2013 Financial Results and Provide a Business Update
PR Newswire - Mon Mar 31, 8:37AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"
today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below: Pressure BioSciences Inc. Exclusive Interview for the Interlinked Investment News Channel on InterlinkedTV
PRWeb - Fri Mar 21, 3:37PM CDT
Pressure BioSciences Inc. was one of the presenting companies interviewed at the recent FSXinterlinked Investment Conference, held at the Ritz Carlton in Dallas, Texas.
Pressure BioSciences Announces the Release and Initial Sale of the Barocycler HUB880, a "First-in-Kind" Ultra High Pressure Bench-top Instrument System
PR Newswire - Wed Mar 19, 9:23AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced the commercial release of the Barocycler HUB880, the newest addition to the Company's growing line of high-pressure instrument systems. The Company also announced the sale (and shipment) of its first HUB880 system to Dr. Wayne Hubbell of the University of California Los Angeles (UCLA). PBI plans to showcase the HUB880 at the upcoming U.S. Human Proteome Organization's 10th Annual Conference to be held at the Westin-Seattle (WA), April 6-9, 2014. Pressure BioSciences, Inc. to Present at the NIBA Florida Investment Conference
PR Newswire - Thu Feb 27, 8:43AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the Florida Investment Conference of the National Investment Banking Association ("NIBA" . The NIBA Investment Conference is being held from February 26-28 at the Riverside Hotel in Ft. Lauderdale, Florida. Mr. Schumacher is scheduled to present today (February 27th) at 2:50 pm EST in the Himarshee Ballroom. TriStar Wellness Solutions® Obtains New Patent for HemCon's Chitosan Technology in Japan
PR Newswire - Wed Feb 12, 7:30AM CST
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has recently been awarded a new patent that supports our emerging status in the Japanese medical/dental markets. Patent application number 2008-537698 has received final approval for issuance to HemCon Medical Technologies® Inc., a wholly owned subsidiary of TriStar Wellness Solutions, and is specific to HemCon's chitosan-based dental sponges for the Japanese market.
Pressure BioSciences Introducing New Technology for Its Pressure Cycling Platform
PRWeb - Thu Jan 16, 5:14AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) record sales in the third-quarter have given the company a bright future. Analysts are even more optimistic about 2014 because the company is going to introduce a breakthrough technology for use in its pressure cycling platform that uses an HT system.
Merriman Capital to Host Pressure BioSciences, Inc. Investor Call at 4:30 p.m. EST on Thursday, December 12, 2013
PR Newswire - Wed Dec 11, 8:02AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced that Merriman Capital, Inc. ("Merriman" , a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), will host an investor call for PBI on Thursday, December 12, 2013 at 4:30 p.m. EST. Pressure BioSciences CEO Richard T. Schumacher and Board Chairman Jeffrey N. Peterson will provide an update on the Company, including a review of the achievements of 2013 and stated goals for 2014, via a webcast with an accompanying PowerPoint presentation. Merriman Capital to Host Pressure BioSciences, Inc. Investor Call
Thomson Reuters ONE - Mon Dec 09, 8:24AM CST
SAN FRANCISCO - December 9, 2013 - Merriman Capital, Inc. ("Merriman"
, a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced today that it will host a conference call for Pressure BioSciences, Inc. ("Pressure BioSciences" (OTCQB: PBIO) on Thursday, December 12, 2013 at 4:30 p.m. EST. Pressure BioSciences CEO Richard T. Schumacher and Chairman Jeffrey N. Peterson will provide comments on the Company with an accompanying presentation. Pressure BioSciences, Inc. -- (PBIO) Featured in Flaherty Financial News Newsletter #40
Marketwire - Mon Nov 25, 8:02AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) led off snapshots of four presentations featured in the November 22, 2013 issue of Flaherty Financial News Newsletter. PBIO's record third quarter and year-to-date 2013 sales, guidance for a strong fourth quarter and expectations to reach breakeven in two years were discussed. However, the highlight was "a core technology breakthrough." CEO Ric Schumacher believes their new high throughput Barocycler instruments will be ready for release by mid-June 2014, and that it is a "game changer." The breakthrough will automate its current highly manual test tube sample preparation system and will allow it to be directly integrated with thousands of downstream instruments now in use by scientists in an estimated 80,000 laboratories worldwide.
Pressure BioSciences, Inc. Discusses Record Third Quarter Revenue, Strong Fourth Quarter Guidance, Significant Progress on New Instrument Systems, and Expectation to Pay-Off All Outstanding Convertible Notes at the SeeThruEquity Financial Conference
PR Newswire - Mon Nov 18, 12:20PM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced that Mr. Richard T. Schumacher, the Company's President and CEO, presented a business and financial update on the Company at the November 12th SeeThruEquity Investor Conference in New York City. Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
PR Newswire - Thu Nov 07, 12:33PM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced record financial results for the three and nine-month periods ended September 30, 2013 and provided a business update. OTC Daily Alert Stock Watch - Pressure BioSciences, Inc. (OTCQB: PBIO)
WorldStockWire - Fri Sep 06, 10:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Kevin Pollack of Pressure BioSciences, Inc. (PBIO)-OTC Markets bought Shares of PBIO
M2 - Mon Aug 26, 9:03AM CDT
Reported by InsiderCow.com at 2013-08-23 14:51:06 ET
Pressure BioSciences, Inc. Reports Second Quarter 2013 Financial Results
PR Newswire - Thu Aug 15, 9:06AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced financial results for the three and six-month periods ended June 30, 2013 and provided a business update. 
